February 21, 2023
Cincinnati-area high school students made their first emulsions and learned about potential careers as part of the Magic of Cosmetic Chemistry workshop hosted by the University of Cincinnati’s James L. Winkle College of Pharmacy’s cosmetic science program.
February 16, 2023
The University of Cincinnati Cancer Center's Sara Medek and Elizabeth Shaughnessy were featured in a Wall Street Journal article commenting on a recent study that found more older women with low-risk breast cancer could forgo radiation after surgery to avoid further side effects.
February 14, 2023
The University of Cincinnati's Joseph Broderick provided comments to Medscape about new trial data that found performing endovascular thrombectomy in stroke patients with a large ischemic core is beneficial.
February 13, 2023
Several national news outlets highlighted the University of Cincinnati's Eva Mistry presenting on the results of the BEST-II trial at the International Stroke Conference.
February 10, 2023
The University of Cincinnati's Eva Mistry presented research that found using medications to lower systolic blood pressure immediately after mechanical clot removal for acute ischemic stroke may not be safe or effective at the International Stroke Conference 2023.
February 10, 2023
The University of Cincinnati's Joseph Broderick commented to HealthDay on the results of a new study finding a "neuroprotectant" drug alongside the standard surgical removal of a clot may lower the risk of death and disability following a stroke.
February 9, 2023
University of Cincinnati Cancer Center clinical oncology dietitian Stacy Shawhan joined 55KRC's Simply Medicine to discuss the myth that sugar feeds cancer cells and helps them grow.
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.
February 7, 2023
The Cincinnati Enquirer highlighted the University of Cincinnati Cancer Center's efforts to become a National Cancer Institute-designated cancer center.
February 7, 2023
The National Cancer Institute (NCI) has announced an intent to fund research from the University of Cincinnati’s Andrew Waters, PhD, to better understand how to overcome treatment resistance and develop better treatments for KRAS-mutated pancreatic cancer.